Diabetes mellitus has an effect on many organ systems including the eye, kidney and peripheral nerve. Many of these complications develop in animal models of diabetes, which has allowed some of the mechanisms of damage in target organs to be studied. Aldose reductase, an intracel lular enzyme, converts glucose to sorbitol, and it is the intracellular accumulation of sorbitol which is thought to result in irreversible damage. In the diabetic eye the increased sorbitol accumulation in both the lens and the retina has been implicated in the pathogenesis of cataract and retinopathy, the major ocular complications of diabetes. In those experimental models which demon strate characteristic diabetic complications, pharma cological inhibition of the enzyme aldose reductase has resulted in prevention of target organ damage. This paper summarises the experimental evidence upon which the clinical trials of aldose reductase inhibitors in diabetic patients have been initiated and the results of published drug trials in these patients.
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INTRACELLULAR GLUCOSE METABOLISM
During normoglycaemia, glucose entering the cell is rap idly phosphorylated by the enzyme hexokinase and enters the Embden-Meyerhof pathway, providing the major aer obic energy source for the cell (Fig. 1 
ANIMAL MODELS OF DIABETIC COMPLICATIONS
Animals such as rats can be rendered diabetic by adminis tration of drugs such as streptozotocin that are toxic to the pancreatic islets. One of the major problems with these animals is that they are sick, become ketotic and often suc cumb to infection, so that they do not live very long. The galactose-fed animal on the other hand, be it rat or dog, has been found to develop many of the complications of chronic diabetes but remains well with a normal blood glucose level.l It is known that galactose is a very good substrate for AR, much better than glucose, and galactose feeding results in the intracellular accumulation of the alcohol galactitol, which is not further metabolised by sor- does not appear to be responsible for cataract formation in this situation. 10 Unfortunately. the role of AR in cataract formation in human diabetics has not been established.
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ARIs have also been administered topically in diabetic rats. There was decreased cataract formation in these rats over a 4-month period, which was associated with decreased lens sorbitol in the treated rats as compared with controls.
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KERATOPATHY
Diabetic corneal epithelium can heal more slowly when traumatised and in studies with diabetic or galactose-fed Blood-retinal barrier permeability in galactose-fed (for II + months) and diabetic (for II + months) rats. (Fig. 2) . In order to examine whether this morphological increase in basement membrane thickness is associated with a functional increase in permeability, the perme ability of the BRB to small molecular weight non-trans ported solutes was quantitatively assessed in vivo at various time points after galactose feeding with and with out concomitant administration of an ARI (sorbinil).19 BRE breakdown occurred after 11 months of galactose feeding and was totally prevented by administration of the ARI (Fig. 3) . Using similar techniques, the same study was repeated in diabetic rather than galactose-fed rats and using another ARI, statil.20 Although BRB breakdown did occur in the diabetic animals, no prevention occurred in the animals concomitantly fed the ARI (Fig. 3) . Signifi cantly increased sorbitol levels were measured in the ret inas of the diabetic rats, including those fed the ARI, suggesting that retinal AR activity was incompletely inhibited. Reversal of retinal pathology has not been possible.
RETINOPATHY TRIALS WITH ALDOSE REDUCTASE INHIBITORS IN MAN
In a large patient study, sorbinil was administered for 3 years at a dosage of 250 mg daily to diabetic patients who 
